<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941028-2-00167</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <TABLE>  <!-- PJG tableformat 6,L2,i1,s100,xls40,xls40,xls40,xs72,xs72 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=95 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=4 --> Table <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=1 -->  2._ <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=4 --> Elements of a Tuberculosis (TB) Infection-Control Program <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Element  <!-- PJG 007 0150 intable --> 1Risk categories  <!-- PJG 007 0150 intable --> 2Minimal  <!-- PJG 007 0150 intable --> 2Very low  <!-- PJG 007 0150 intable --> 2Low  <!-- PJG 007 0150 intable --> 2Intermediate  <!-- PJG 007 0150 intable --> 2High  <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=4 --> Assigning responsibility (Section II.A) <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=4 --> Designated TB control officer or committee  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=4 --> Conducting a risk assessment (Section II.B.1) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=4 --> Baseline risk assessment  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Community TB profile: incidence, prevalence, and drug-susceptibility patterns  <!-- PJG 007 0104 intable --> Y  <!-- PJG 007 0104 intable --> Y  <!-- PJG 007 0104 intable --> Y  <!-- PJG 007 0104 intable --> Y  <!-- PJG 007 0104 intable --> Y <!-- PJG 0012 frnewline --> Facility case surveillance (laboratory- and discharge-diagnosis-based)  <!-- PJG 007 0104 intable --> C  <!-- PJG 007 0104 intable --> C  <!-- PJG 007 0104 intable --> C  <!-- PJG 007 0104 intable --> C  <!-- PJG 007 0104 intable --> C <!-- PJG 0012 frnewline --> Analysis of purified protein derivative (PPD) test results among health-care workers (HCWs)  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> V*  <!-- PJG 007 0104 intable --> Y  <!-- PJG 007 0104 intable --> Every 6&hyph;12 mos  <!-- PJG 007 0104 intable --> Every 3 mos. <!-- PJG 0012 frnewline --> Review of TB patient medical records  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> O <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 -->  <!-- PJG 0036 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 -->   <!-- PJG 007 0104 intable --> Y  <!-- PJG 007 0104 intable --> Every 6&hyph;12 mos  <!-- PJG 007 0104 intable --> Every 3 mos. <!-- PJG 0012 frnewline --> Observation of infection-control practices  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> Y  <!-- PJG 007 0104 intable --> Every 6&hyph;12 mos  <!-- PJG 007 0104 intable --> Every 3 mos. <!-- PJG 0012 frnewline --> Evaluation of engineering control maintenance  <!-- PJG 007 0104 intable --> O <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 -->   <!-- PJG 007 0104 intable --> O <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 -->   <!-- PJG 007 0104 intable --> Y  <!-- PJG 007 0104 intable --> Every 6&hyph;12 mos  <!-- PJG 007 0104 intable --> Every 3 mos. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Developing a TB infection control plan (Section II.B.2) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Written TB infection control plan  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Periodically reassessing risk (Section II.B.3) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Reassessment of risk  <!-- PJG 007 0104 intable --> Y  <!-- PJG 007 0104 intable --> Y  <!-- PJG 007 0104 intable --> Y  <!-- PJG 007 0104 intable --> Every 6&hyph;12 mos  <!-- PJG 007 0104 intable --> Every 3 mos. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Identifying, evaluating, and initiating treatment for patients who may have active TB (Section II.C) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Protocol (clinical prediction rules <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 --> &para; <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 -->  for identifying patients who may have active TB  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Protocol for diagnostic evaluation of patients who may have active TB**  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Protocol for reporting laboratory results to clinicians, infection-control practitioners, collaborating referral facilities, and appropriate health department(s)  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Protocol for initiating treatment of patients who may have active TB**  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Managing patients who may have TB in ambulatory-care settings and emergency departments (Section II.D) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Triage system for identifying patients who have active TB in emergency departments and ambulatory-care settings  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Protocol for managing patients who may have active TB in emergency departments and ambulatory-care settings  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Protocol for referring patients who may have active TB to collaborating facility  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> N/A <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 -->  <!-- PJG 0036 unknown -->  <!-- PJG 0036 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 -->   <!-- PJG 007 0104 intable --> N/A <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 -->  <!-- PJG 0036 unknown -->  <!-- PJG 0036 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 -->   <!-- PJG 007 0104 intable --> N/A <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 -->  <!-- PJG 0036 unknown -->  <!-- PJG 0036 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Managing hospitalized patients who may have TB (Section II.E) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Appropriate number of TB isolation roomsN/A <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 -->   <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Protocol for initiating TB isolation  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Protocol for TB isolation practices  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Protocol for discontinuing TB isolation  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Protocol for discharge planning  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Engineering controls (Suppl. 3, Section II.F) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Protocol(s) for maintenance of engineering controls  <!-- PJG 007 0104 intable --> O <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 -->   <!-- PJG 007 0104 intable --> O <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 -->   <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Respiratory protection (Suppl. 4, Section II.G) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Respiratory protection program  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> V*  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Cough-inducing and aerosol-generating procedures (Section II.H) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Protocol(s) for performing cough-inducing or aerosol-generating procedures  <!-- PJG 007 0104 intable --> O  <!-- PJG 007 0104 intable --> O <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 --> &para;&para; <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 -->   <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Engineering controls for performing cough-inducing or aerosol-generating procedures  <!-- PJG 007 0104 intable --> O <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 -->   <!-- PJG 007 0104 intable --> O <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 --> &para;&para; <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 -->   <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Educating and Training HCWs (Section II.I) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Educating and training HCWs regarding TB  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Counseling and screening HCWs (Section II.J) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Counseling HCWs regarding TB  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Protocol for identifying and evaluating HCWs who have signs or symptoms of active TB  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Baseline PPD testing of HCWs  <!-- PJG 007 0104 intable --> O***  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Routine periodic PPD screening of HCWs for latent TB infection  <!-- PJG 007 0104 intable --> N/A  <!-- PJG 007 0104 intable --> V*  <!-- PJG 007 0104 intable --> Y  <!-- PJG 007 0104 intable --> Every 6&hyph;12 mos  <!-- PJG 007 0104 intable --> Every 3 mos. <!-- PJG 0012 frnewline --> Protocol for evaluating and managing HCWs who have positive PPD tests  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Protocol for managing HCWs who have active TB  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Conducting a problem evaluation (Section II.K) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Protocol for investigating PPD conversions and active TB in HCWs  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Protocol for investigating possible patient-to-patient transmission of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=3 --> Mycobacterium tuberculosis <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 -->   <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline --> Protocol for investigating possible contacts of TB patients who were not diagnosed initially as having TB and were not placed in isolation  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Coordination with the public health department (Section II.L) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Effective system for reporting patients who have suspected or confirmed TB to appropriate health department(s)  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R  <!-- PJG 007 0104 intable --> R <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable --> R=recommended; Y=yearly; C=continual; N/A=not applicable; O=optional; V=variable. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable --> *Because very low-risk facilities do not admit patients who may have active TB to inpatient areas, most HCWs in such facilities do not need routine follow-up PPD screening after baseline PPD testing is done. However, those who are involved in the initial assessment and diagnostic evaluation of patients in the ambulatory-care, emergency, and admitting departments of such facilities or in the outpatient management of patients with active TB could be exposed potentially to a patient who has active TB. These HCWs may need to receive routine periodic PPD screening. Similarly, these HCWs may need to be included in a respiratory protection program. <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable -->  <!-- PJG ITAG l=03 g=5 f=1 -->  <!-- PJG 0036 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Because very low-risk facilities do not admit patients suspected of having active TB, review of TB patient medical records is not applicable. However, follow-up of patients who were identified during triage as possibly having active TB and referred to another institution for further evaluation and management may be useful in evaluating the effectiveness of the triage system.  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Some minimal or very low-risk facilities may elect to use engineering controls (e.g., booths for cough-inducing procedures, portable high-efficiency particulate [HEPA] filtration units, ultraviolet germicidal irradiation units) in triage/waiting areas. In such situations, appropriate protocols for maintaining this equipment should be in place, and this maintenance should be evaluated periodically. <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 --> &para; <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> The criteria used in clinical prediction rules will probably vary from facility to facility depending on the prevalence of TB in the population served by the facility and on the clinical, radiographic, and laboratory characteristics of TB patients examined in the facility.  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable --> **The protocols should be consistent with CDC/American Thoracic Society recommendations ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=3 --> 33 <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> ). <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 -->  <!-- PJG 0036 unknown -->  <!-- PJG 0036 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Protocols for referring patients who require specialized treatment (e.g., patients with multidrug-resistant TB) may be appropriate.  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Based on maximum daily number of patients requiring TB isolation for suspected or confirmed active TB. Isolation rooms should meet the performance criteria specified in these guidelines.  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=5 f=1 --> &para;&para; <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> If such procedures are used in the triage protocol(s) for identifying patients who may have active TB. <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable --> ***Minimal-risk facilities do not need to maintain an ongoing PPD skin-testing program. However, baseline PPD testing of HCWs may be advisable so that if an unexpected exposure does occur, conversions can be distinguished from positive PPD test results caused by previous exposures.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            